
Athletes with a genetic heart disease are often disqualified from participating in competitive sports because of the perceived risk of sudden cardiac arrest. While the clinicians' intent may be understandable, is it necessarily the best approach?
Mayo Clinic researchers conducted a review of athletes who were treated at Mayo during a 20-year period, and their findings published in Mayo Clinic Proceedings suggest that after the patient’s condition has been properly evaluated and treated, an athlete’s safe return to play is feasible, even with an implantable cardioverter-defibrillator (ICD).
"Although the risk of a disease-triggered breakthrough cardiac event is not zero, the data in our study finds that athletes with ICDs may safely participate in higher-intensity sports with minimal risk of damage to the device during competition or other adverse events," says Michael Ackerman, M.D., Ph.D., a genetic cardiologist at Mayo Clinic and the article's senior author. "Before this can occur, however, the athlete must undergo a full clinical evaluation with a thorough understanding of potential risks and a treatment plan that’s well-understood and adhered to."
Read the rest of the article on the Discovery's Edge blog.
____________________________________________
Other Mayo Clinic medical research websites:
ROCHESTER, Minn. — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of ...
ROCHESTER, Minn. — Heart failure is a potentially urgent health concern for young adults with congenital heart disease (ACHD) that is often overlooked and undertreated, ...
Mayo Clinic doctors are using innovation to improve the lives of people who suffer from congestive heart failure and other chronic heart conditions. The Organ ...